Kanagawa, Japan

Takeo Iida

This inventor holds 3 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takeo Iida. Retrieved from https://idiyas.com/inventor/takeo-iida-o6gxslpa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 21.0

ph-index = 2

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Takeo Iida: Innovator in Peptide-Compound Cyclization

Introduction

Takeo Iida is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of drug discovery through his innovative methods for cyclizing peptide compounds. With a total of 3 patents to his name, Iida is recognized for his expertise and dedication to advancing pharmaceutical research.

Latest Patents

One of Iida's latest patents is a peptide-compound cyclization method. The objective of this invention is to provide methods for discovering drugs that are effective for challenging targets, which have traditionally been difficult to identify. This invention relates to novel methods for cyclizing peptide compounds, as well as novel peptide compounds and libraries that comprise these compounds, aimed at achieving the aforementioned objective.

Career Highlights

Iida has established himself as a key figure in the pharmaceutical industry, particularly through his work at Chugai Seiyaku Kabushiki Kaisha. His innovative approaches have garnered attention and respect within the scientific community, contributing to advancements in drug development.

Collaborations

Iida has collaborated with notable coworkers, including Shiori Kariyuki and Miki Kojima. These partnerships have further enhanced his research and development efforts, leading to impactful innovations in the field.

Conclusion

Takeo Iida's work in peptide-compound cyclization represents a significant advancement in drug discovery. His innovative methods and collaborations continue to influence the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…